Log in

Experts’ recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To highlight and compare experts’ laser settings during endoscopic laser treatment of upper tract urothelial carcinoma (UTUC), to identify measures to reduce complications, and to propose guidance for endourologists.

Methods

Following a focused literature search to identify relevant questions, a survey was sent to laser experts. We asked participants for typical settings during specific scenarios (ureteroscopy (URS), retrograde intrarenal surgery (RIRS), and percutaneous treatment). These settings were compared among the reported laser types to find common settings and limits. Additionally, we identified preventive measures commonly applied during surgery.

Results

Twenty experts completed the survey, needing a mean time of 12.7 min. Overall, most common laser type was Holmium–Yttrium–Aluminum–Garnet (Ho:YAG) (70%, 14/20) followed by Thulium fiber laser (TFL) (45%, 9/20), pulsed Thulium–Yttrium–Aluminum–Garnet (Tm:YAG) (3/20, 15%), and continuous wave (cw)Tm:YAG (1/20, 5%). Pulse energy for the treatment of distal ureteral tumors was significantly different with median settings of 0.9 J, 1 J and 0.45 J for Ho:YAG, TFL and pulsed Tm:YAG, respectively (p = 0.048). During URS and RIRS, pulse shapes were significantly different, with Ho:YAG being used in long pulse and TFL in short pulse mode (all p < 0.05). We did not find further disparities.

Conclusion

Ho:YAG is used by most experts, while TFL is the most promising alternative. Laser settings largely do not vary significantly. However, further research with novel lasers is necessary to define the optimal approach. With the recent introduction of small caliber and more flexible scopes, minimal-invasive UTUC treatment is further undergoing an extension of applicability in appropriately selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

References

  1. Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM et al (2021) European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79(1):62–79. https://doi.org/10.1016/j.eururo.2020.05.042

    Article  CAS  PubMed  Google Scholar 

  2. Baard J, Freund JE, de la Rosette JJ, Laguna MP (2017) New technologies for upper tract urothelial carcinoma management. Curr Opin Urol 27(2):170–175. https://doi.org/10.1097/mou.0000000000000373

    Article  PubMed  Google Scholar 

  3. Jung H, Giusti G, Fajkovic H, Herrmann T, Jones R, Straub M et al (2019) Consultation on UTUC, Stockholm 2018: aspects of treatment. World J Urol 37(11):2279–2287. https://doi.org/10.1007/s00345-019-02811-w

    Article  PubMed  PubMed Central  Google Scholar 

  4. Villa L, Haddad M, Capitanio U, Somani BK, Cloutier J, Doizi S et al (2018) Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium: YAG laser photoablation? Long-term results from a high volume institution. J Urol 199(1):66–73. https://doi.org/10.1016/j.juro.2017.07.088

    Article  PubMed  Google Scholar 

  5. Sanguedolce F, Fontana M, Turco M, Territo A, Lucena JB, Cortez JC et al (2021) Endoscopic management of upper urinary tract urothelial carcinoma: oncologic outcomes and prognostic factors in a contemporary cohort. J Endourol 35(11):1593–1600. https://doi.org/10.1089/end.2021.0133

    Article  PubMed  Google Scholar 

  6. Defidio L, Antonucci M, De Dominicis M, Fuchs G, Patel A (2019) Thulium-holmium: YAG duo laser in conservative upper tract urothelial cancer treatment: 13 years experience from a tertiary national referral center. J Endourol 33(11):902–908. https://doi.org/10.1089/end.2019.0308

    Article  PubMed  Google Scholar 

  7. Breda A, Territo A, Sanguedolce F (2020) Combination of holmium and thulium laser ablation in upper tract urothelial carcinoma. World J Urol 38(10):2661–2662. https://doi.org/10.1007/s00345-020-03124-z

    Article  PubMed  Google Scholar 

  8. Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S et al (2018) Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes. J Endourol 32(3):257–263. https://doi.org/10.1089/end.2017.0915

    Article  PubMed  Google Scholar 

  9. Wen J, Ji ZG, Li HZ (2018) Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study. BMC Cancer 18(1):196. https://doi.org/10.1186/s12885-018-4118-y

    Article  PubMed  PubMed Central  Google Scholar 

  10. Proietti S, Johnston T, Pupulin M, Di Pietro S, Spagna S, Rico L et al (2022) Effectiveness and safety of thulium fiber laser in the conservative management of patients with upper tract urothelial carcinoma. Eur Urol Open Sci 46:99–104. https://doi.org/10.1016/j.euros.2022.10.010

    Article  PubMed  PubMed Central  Google Scholar 

  11. Taratkin M, Singla N, Babaevskaya D, Androsov A, Shariat SF, Fajkovic H et al (2023) A review of how lasers are used in UTUC surgery: can the choice of laser affect outcomes? Cancers. https://doi.org/10.3390/cancers15061874

    Article  PubMed  PubMed Central  Google Scholar 

  12. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22(2):338–342. https://doi.org/10.1096/fj.07-9492LSF

    Article  CAS  PubMed  Google Scholar 

  13. Enikeev D, Taratkin M (2023) Thulium fiber laser: bringing lasers to a whole new level. Eur Urol Open Sci 48:31–33. https://doi.org/10.1016/j.euros.2022.07.007

    Article  PubMed  Google Scholar 

  14. Taratkin M, Kovalenko A, Laukhtina E, Paramonova N, Spivak L, Wachtendorf LJ et al (2022) Ex vivo study of Ho: YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Lasers Med Sci 37(1):149–154. https://doi.org/10.1007/s10103-020-03189-7

    Article  PubMed  Google Scholar 

  15. Proietti S, Rodríguez-Socarrás ME, Eisner BH, Lucianò R, Basulto Martinez MJ, Yeow Y et al (2021) Thulium:YAG versus holmium: YAG laser effect on upper urinary tract soft tissue: evidence from an ex vivo experimental study. J Endourol 35(4):544–551. https://doi.org/10.1089/end.2020.0222

    Article  PubMed  Google Scholar 

  16. Ortner G, Rice P, Nagele U, Herrmann TRW, Somani BK, Tokas T (2023) Tissue thermal effect during lithotripsy and tissue ablation in endourology: a systematic review of experimental studies comparing Holmium and Thulium lasers. World J Urol 41(1):1–12. https://doi.org/10.1007/s00345-022-04242-6

    Article  CAS  PubMed  Google Scholar 

  17. Huusmann S, Lafos M, Meyenburg I, Muschter R, Teichmann HO, Herrmann T (2021) Tissue effects of a newly developed diode pumped pulsed Thulium:YAG laser compared to continuous wave thulium: YAG and pulsed holmium: YAG laser. World J Urol 39(9):3503–3508. https://doi.org/10.1007/s00345-021-03634-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Becker B, Enikeev D, Glybochko P, Rapoport L, Taratkin M, Gross AJ et al (2020) Effect of optical fiber diameter and laser emission mode (cw vs pulse) on tissue damage profile using 1.94 µm Tm: fiber lasers in a porcine kidney model. World J Urol 38(6):1563–1568. https://doi.org/10.1007/s00345-019-02944-y

    Article  CAS  PubMed  Google Scholar 

  19. Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P et al (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67(6):1181–1187. https://doi.org/10.1016/j.urology.2005.12.034

    Article  PubMed  Google Scholar 

  20. Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F et al (2007) Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51(3):709–713. https://doi.org/10.1016/j.eururo.2006.07.019. (discussion 14)

    Article  PubMed  Google Scholar 

  21. Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu JN et al (2016) Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34(9):1201–1206. https://doi.org/10.1007/s00345-015-1753-7

    Article  PubMed  Google Scholar 

  22. Ortner G, Pang KH, Yuan Y, Herrmann TRW, Biyani CS, Tokas T (2023) Peri- and post-operative outcomes, complications, and functional results amongst different modifications of endoscopic enucleation of the prostate (EEP): a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-023-04308-z

    Article  PubMed  Google Scholar 

  23. Gauhar V, Gilling P, Pirola GM, Chan VW, Lim EJ, Maggi M et al (2022) Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a Systematic review and meta-analysis of comparative studies. Eur Urol Focus 8(5):1362–1369. https://doi.org/10.1016/j.euf.2022.01.013

    Article  PubMed  Google Scholar 

  24. Enikeev D, Taratkin M, Azilgareeva C, Glybochko P (2020) Knowing the inside of a laser. Arch Esp Urol 73(8):665–674

    PubMed  Google Scholar 

  25. Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG et al (2023) Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies. Eur Urol Open Sci 49:60–66. https://doi.org/10.1016/j.euros.2023.01.004

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yonese I, Ito M, Waseda Y, Kobayashi S, Toide M, Takazawa R et al (2023) Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. https://doi.org/10.1007/s00345-023-04446-4

    Article  PubMed  Google Scholar 

  27. Douglawi A, Ghoreifi A, Lee R, Yip W, Seyedian SSL, Ahmadi H et al (2022) Bladder recurrence following diagnostic ureteroscopy in patients undergoing nephroureterectomy for upper tract urothelial cancer: is ureteral access sheath protective? Urology 160:142–146. https://doi.org/10.1016/j.urology.2021.11.026

    Article  PubMed  Google Scholar 

  28. Tokas T, Skolarikos A, Herrmann TRW, Nagele U (2019) Pressure matters 2: intrarenal pressure ranges during upper-tract endourological procedures. World J Urol 37(1):133–142. https://doi.org/10.1007/s00345-018-2379-3

    Article  PubMed  Google Scholar 

  29. Rice P, Somani BK, Nagele U, Herrmann TRW, Tokas T (2022) Generated temperatures and thermal laser damage during upper tract endourological procedures using the holmium: yttrium-aluminum-garnet (Ho: YAG) laser: a systematic review of experimental studies. World J Urol 40(8):1981–1992. https://doi.org/10.1007/s00345-022-03992-7

    Article  CAS  PubMed  Google Scholar 

  30. Fero KE, Shan Y, Lec PM, Sharma V, Srinivasan A, Movva G et al (2021) Treatment patterns, outcomes, and costs associated with localized upper tract urothelial carcinoma. JNCI Cancer Spectr. https://doi.org/10.1093/jncics/pkab085

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

GO and TT had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: TT. Acquisition of data: GO, TT, BKS, SG, GK, OT, GG, SP, EL, PK, ØU, IKG, MD, JB, GMK, SF, LD, LV, AM, TT, AP, SBH, AP, ASG, TH, UN. Analysis and interpretation: GO, TT. Drafting of the manuscript: GO, TT. Critical revision of the manuscript: TT, BKS, SG, TH, UN, ASG. Statistical analysis: GO. Obtaining funding: None. Administrative, technical, or material support: GO, TT, UN, TH. Supervision: TT.

Corresponding author

Correspondence to Gernot Ortner.

Ethics declarations

Conflict of interest

Gernot Ortner certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Thomas Tailly: Consultant Boston Scientific, Cook Medical, Dornier, Storz. Guido Kamphuis: Advisory board: Boston Scientific, Olympus, Honoraria: Alnylam, Boston Scientific, Coloplast Porgès, Olympus. Amelia Pietropaolo: Consultant Boston Scientific, Ambu, Pusen. Panagiotis Kallidonis: Consultant Cook Medical, EMS. Mordechai Duvdevani: Consultant Boston Scientific. Udo Nagele: Consultant Baxter, Boston Scientific, Optimed, Storz medical, B + K. Laurian Dragos: Consultant EMS, Boston Scientific, Ambu. Silvia Proietti: Consultant Boston Scientific. Joyce Baard: Consultant Coloplast, Boston Scientific, Olympus, Urogen. Øyvind Ulvik: Lectures Olympus.

Research involving human participants and/or animals

This review does not involve human participants and/or animals.

Informed consent

No patients were included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material. 

Supplementary file1 (DOCX 27 KB)

Supplementary file2 (XLSX 29 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortner, G., Somani, B.K., Güven, S. et al. Experts’ recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group. World J Urol 41, 3367–3376 (2023). https://doi.org/10.1007/s00345-023-04632-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-023-04632-4

Keywords

Navigation